Sangeetha Reddy
@smreddymd
Breast cancer medical oncologist, translational researcher and clinical trialist with focus on immunotherapy and the tumor microenvironment
ID: 896574803510935553
13-08-2017 03:31:05
370 Tweet
768 Followers
143 Following
Incredible presentation at #SABCS2022 on InteractPrint by Student Doctor Lily Xu from Isaac Chan, MD, PhD Lab! Stellar mentorship by Dr. Chan to feature this rising star at a general session! Grateful for this incredible collaboration Sangeetha Reddy UTSW Simmons Cancer Center and excited for more to come!
Carlos L. Arteaga, M.D. Carlos: Thank you so much for the opportunity!
Excited to share our work with Anna Vilgelm showing dendritic cell therapy augments anti-tumor immunity with CDK4/6i and immune checkpoint blockade! jitc.bmj.com/content/11/5/e…
Highlighting the important role the innate immune system plays in immunotherapy, Sangeetha Reddy delivers an excellent lecture describing the rationale for augmenting CDK4/6i and ICB with dendritic cell therapy. #DAVAHawaiiBreast jitc.bmj.com/content/11/5/e…
It is not uncommon for clinician scientists to be questioned whether they’re ‘real doctors’ or ‘true scientists’ Both The secret to a long life as a clinician scientist is the same as a long marriage. Selective deafness Great paper ESMO Open Jon Lim, MRCP PhD esmoopen.com/article/S2059-…
Fantastic talk at #SITC2023 by Brekkenlab UTSW Simmons Cancer Center on Immune Regulation by Stromal Cells!
Tumor Agnostic Approaches to Care: Vivek Subbiah, MD, Joshua Z. Drago, Mia Levy, MD, PhD, and Marleen Kok addressed this topic in a Clinical Workshop moderated by Sangeetha M. Reddy this afternoon at #SABCS23. MarleenKokLab Sangeetha Reddy AACR @UTHealthSAMDA OncoAlert
After my wonderful experience at MD Anderson Cancer Center, I've realized there is a robust academic life beyond it. Certainly, those who remain at or return to MDA also enjoy fulfilling careers. I've learned that various cancer centers contribute uniquely to breast cancer research.
#SABCS23 | Poster PO2-27-12 | Genomic determinants of benefit to nivolumab + low dose ipilimumab among patients with hypermutated HER2- #MBC: Results of #NIMBUS trial. #MetastaticBreastCancer Romualdo Barroso, MD PhD Sara Tolaney Nancy Lin, MD @nabihahtayob @emittendorfmd Rinath Jeselsohn Sangeetha Reddy
Excited to share our updated pre-clinical data on combination CD40 agonist + Flt3L + Doxil in breast cancer with @PreteeshLeo. UTSW Simmons Cancer Center #aacr24
UTSW Internal Medicine #GrandRounds with Sangeetha Reddy highlighting immunotherapy for breast cancer and her translational efforts. Our breast cancer team is strong UTSW Simmons Cancer Center UTSW Hematology & Oncology! Carlos L. Arteaga, M.D. Suzanne Conzen Heather McArthur, MD, MPH, FASCO
Big congratulations Sangeetha Reddy UTSW Simmons Cancer Center !!
#AACR25, capturing the last night at AACR grantee award reception along with UTSW Simmons Cancer Center colleague Sangeetha Reddy ! Managed to take a photo with the one and only Margaret Foti, PhD, MD (hc) !Thanks the grant support from AACR KidneyCAN